Drug Profile
MTIP
Alternative Names: CRHR1 receptor antagonist (MTIP) - Eli Lilly and CompanyLatest Information Update: 30 Apr 2013
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alcoholism
Most Recent Events
- 30 Apr 2013 Discontinued - Phase-I for Alcoholism in USA (PO)
- 31 Dec 2009 Phase-I clinical trials in Alcoholism in USA (PO)
- 21 Oct 2009 Pharmacodynamics data from a preclinical trial in rodents presented at the 39th Annual Meeting of the Society for Neuroscience (SfN-2009)